Skip to main content
. 2016 Jul;8(7):1587–1600. doi: 10.21037/jtd.2016.06.01

Figure 4.

Figure 4

Overall analysis for the prognostic value of Oct-4 expression for OS in patients with NSCLC. AC, adenocarcinoma; CI, confidence interval; HR, hazard ratio; NSCLC, non-small cell lung cancer; Oct-4, octamer-binding transcription factor 4; OS, overall survival; SCC, squamous cell carcinoma.